$NVDA stock rose 3% this week, according to our price data from Polygon.
It has been the 3rd most-searched ticker on Quiver Quantitative over the last week, out of 50 total tickers searched.
Here is what we see in our data on $NVDA (you can track the company live on Quiver's $NVDA stock page):
$NVDA Insider Trading Activity
$NVDA insiders have traded $NVDA stock on the open market 360 times in the past 6 months. Of those trades, 0 have been purchases and 360 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by insiders over the last 6 months:
- JEN HSUN HUANG (President and CEO) has made 0 purchases and 215 sales selling 3,075,000 shares for an estimated $554,194,068.
- MARK A STEVENS has made 0 purchases and 5 sales selling 1,420,297 shares for an estimated $253,987,187.
- HARVEY C JONES has made 0 purchases and 2 sales selling 500,000 shares for an estimated $88,387,150.
- AJAY K PURI (EVP, Worldwide Field Ops) has made 0 purchases and 4 sales selling 400,000 shares for an estimated $73,570,779.
- DEBORA SHOQUIST (EVP, Operations) has made 0 purchases and 20 sales selling 309,840 shares for an estimated $56,186,171.
- COLETTE KRESS (EVP & Chief Financial Officer) has made 0 purchases and 96 sales selling 291,560 shares for an estimated $53,651,288.
- DONALD F JR ROBERTSON (Principal Accounting Officer) has made 0 purchases and 12 sales selling 108,090 shares for an estimated $20,230,766.
- DAWN E HUDSON has made 0 purchases and 2 sales selling 90,000 shares for an estimated $15,381,064.
- PERSIS DRELL sold 40,000 shares for an estimated $7,106,120
- STEPHEN C NEAL sold 28,000 shares for an estimated $4,972,343
- A BROOKE SEAWELL sold 12,728 shares for an estimated $2,341,117
- JOHN DABIRI sold 626 shares for an estimated $112,316
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NVDA Hedge Fund Activity
We have seen 2,553 institutional investors add shares of $NVDA stock to their portfolio, and 2,598 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 589,595,243 shares (-75.1%) from their portfolio in Q4 2025, for an estimated $109,959,512,819
- J. STERN & CO. LLP added 124,849,603 shares (+13709.1%) to their portfolio in Q4 2025, for an estimated $23,284,450,959
- CARDANO RISK MANAGEMENT B.V. added 70,283,539 shares (+896.4%) to their portfolio in Q4 2025, for an estimated $13,107,880,023
- VANGUARD GROUP INC added 43,149,475 shares (+1.9%) to their portfolio in Q4 2025, for an estimated $8,047,377,087
- SG AMERICAS SECURITIES, LLC added 35,712,890 shares (+1703.0%) to their portfolio in Q4 2025, for an estimated $6,660,453,985
- JPMORGAN CHASE & CO removed 32,478,144 shares (-6.6%) from their portfolio in Q4 2025, for an estimated $6,057,173,856
- SOFTBANK GROUP CORP. removed 32,110,456 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $5,988,600,044
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NVDA Congressional Stock Trading
Members of Congress have traded $NVDA stock 24 times in the past 6 months. Of those trades, 11 have been purchases and 13 have been sales.
Here’s a breakdown of recent trading of $NVDA stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 5 times. They made 3 purchases worth up to $80,000 on 01/30, 11/18, 10/17 and 2 sales worth up to $65,000 on 12/24, 12/19.
- REPRESENTATIVE DANIEL MEUSER has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/30, 01/14.
- REPRESENTATIVE JOHN MCGUIRE purchased up to $15,000 on 01/30.
- REPRESENTATIVE NANCY PELOSI has traded it 2 times. They made 1 purchase worth up to $500,000 on 01/16 and 1 sale worth up to $5,000,000 on 12/24.
- SENATOR SHELDON WHITEHOUSE has traded it 4 times. They made 0 purchases and 4 sales worth up to $130,000 on 01/09, 10/20, 09/04.
- SENATOR MARKWAYNE MULLIN purchased up to $250,000 on 12/29.
- REPRESENTATIVE DWIGHT EVANS purchased up to $15,000 on 11/21.
- SENATOR KATIE BOYD BRITT sold up to $15,000 on 11/07.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $50,000 on 10/30 and 2 sales worth up to $100,000 on 10/31, 10/30.
- REPRESENTATIVE CLEO FIELDS has traded it 3 times. They made 3 purchases worth up to $400,000 on 10/30, 09/03 and 0 sales.
- REPRESENTATIVE VAL T. HOYLE sold up to $100,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$NVDA Analyst Ratings
Wall Street analysts have issued reports on $NVDA in the last several months. We have seen 28 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/18/2026
- RBC Capital issued a "Outperform" rating on 01/15/2026
- Mizuho issued a "Outperform" rating on 01/09/2026
- Truist Securities issued a "Buy" rating on 12/29/2025
- Stifel issued a "Buy" rating on 12/29/2025
- B of A Securities issued a "Buy" rating on 12/26/2025
- Bernstein issued a "Outperform" rating on 12/26/2025
To track analyst ratings and price targets for $NVDA, check out Quiver Quantitative's $NVDA forecast page.
$NVDA Price Targets
Multiple analysts have issued price targets for $NVDA recently. We have seen 33 analysts offer price targets for $NVDA in the last 6 months, with a median target of $265.0.
Here are some recent targets:
- N. Quinn Bolton from Needham set a target price of $240.0 on 02/18/2026
- Blayne Curtis from Jefferies set a target price of $275.0 on 01/16/2026
- Srini Pajjuri from RBC Capital set a target price of $240.0 on 01/15/2026
- Vijay Rakesh from Mizuho set a target price of $275.0 on 01/09/2026
- William Stein from Truist Securities set a target price of $275.0 on 12/29/2025
- Ruben Roy from Stifel set a target price of $250.0 on 12/29/2025
- Tristan Gerra from Baird set a target price of $275.0 on 12/26/2025
You can track data on $NVDA on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
